The emerging role of Rituximab in the treatment of large granular lymphocytic leukemia associated with rheumatoid arthritis: a single center experience
ARP Rheumatology · 2024
DOI: 10.63032/dnpz5424 ↗Kurz gefasst
Fallbericht in der Zeitschrift ARP Rheumatology, 2024. Verfasst von Mariana Diz Lopes und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro Hospitalar Universitário de São João, Porto, Portugal. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid, Leukemia, Large Granular Lymphocytic, Rituximab.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro Hospitalar Universitário de São João, Porto, Portugal.
- Centro Hospitalar Tondela-Viseu, Viseu, Portugal.
Zitieren
APA
Diz Lopes, M., Marques Gomes, C., Santos, I., Martins-Rocha, T., Bernardes, M., Pinto, J., & Costa, L. (2024). The emerging role of Rituximab in the treatment of large granular lymphocytic leukemia associated with rheumatoid arthritis: a single center experience. ARP Rheumatology. https://doi.org/10.63032/dnpz5424
Vancouver
Diz Lopes M, Marques Gomes C, Santos I, Martins-Rocha T, Bernardes M, Pinto J, et al. The emerging role of Rituximab in the treatment of large granular lymphocytic leukemia associated with rheumatoid arthritis: a single center experience. ARP Rheumatology. 2024. doi:10.63032/dnpz5424
BibTeX
@article{DizLopes2024,
author = {Diz Lopes, Mariana and Marques Gomes, Carlos and Santos, Inês and Martins-Rocha, Teresa and Bernardes, Miguel and Pinto, José and Costa, Lúcia},
title = {The emerging role of Rituximab in the treatment of large granular lymphocytic leukemia associated with rheumatoid arthritis: a single center experience},
journal = {ARP Rheumatology},
year = {2024},
doi = {10.63032/dnpz5424}
}
EUVIMED